H. Rupprecht

Uniform Manifold Approximation and Projection-based Assessment of Chronic Kidney Disease Aetiologies based on Urinary Peptidomics

A. Vlahou, H. Mischak, J. Schanstra, 2023, medRxiv.

Predictive performance and clinical application of COV50, a urinary proteomic biomarker in early COVID-19 infection: a prospective multicentre cohort study

A. Mebazaa, Bjoern Peters, J. Staessen, 2022, The Lancet Digital Health.

Microangiopathy in multiple myeloma: a case of carfilzomib-induced secondary thrombotic microangiopathy successfully treated with plasma exchange and complement inhibition

L. Catanese, Katharina Link, H. Rupprecht, 2023, BMC Nephrology.

A Novel Urinary Proteomics Classifier for Non-Invasive Evaluation of Interstitial Fibrosis and Tubular Atrophy in Chronic Kidney Disease

H. Mischak, K. Amann, E. Mavrogeorgis, 2021, Proteomes.

Recent Advances in Urinary Peptide and Proteomic Biomarkers in Chronic Kidney Disease: A Systematic Review

H. Mischak, J. Siwy, R. Wendt, 2023, International journal of molecular sciences.

Angiopoietin 1 and 2 gene and protein expression is differentially regulated in acute anti-Thy1.1 glomerulonephritis.

V. Câmpean, Britta Karpe, H. Rupprecht, 2008, American journal of physiology. Renal physiology.

Urinary peptidomic liquid biopsy for non-invasive differential diagnosis of chronic kidney disease

A. Vlahou, J. Schanstra, A. Latosinska, 2023, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Differentiating primary and secondary FSGS using non-invasive urine biomarkers

W. Mullen, R. Wendt, J. Beige, 2023, Clinical kidney journal.